Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tetragenex Pharmaceuticals, Inc. (TTRX) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Tetragenex Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1362659.
Total stock buying since 2007: $6,900.
Total stock sales since 2007: $0.
Total stock option exercises since 2007: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2007 | 20,000 | $6,900 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2007-11 | 20,000 | $6,900 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-11-29 | Cohen Aaron (Director) | Buy | 10,000 | .34 | 3,400 |
| 2007-11-26 | Cohen Aaron (Director) | Buy | 10,000 | .35 | 3,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of TTRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tetragenex Pharmaceuticals, Inc. (symbol TTRX, CIK number 1362659) see the Securities and Exchange Commission (SEC) website.